Search
for
Sort by
Research 601–630 of 1000+
- Prostaglandins: Key players in immunomodulation of the nervous system
- The Use of 308-nm Excimer Laser Therapy in Alopecia Areata and Primary Cicatricial Alopecia: A Systematic Review
- UV Protection Habits and Preferences in Patients With Distinct Cutaneous Immune‐Mediated Inflammatory Diseases
- Reducing Disease Activity in Systemic Lupus Erythematosus through Adjunctive Naturopathy and Yoga: A Six-Month Case Report with Serial Immunological, Haematological, and Patient-Reported Outcome Monitoring
- Real‐World Clinical Outcomes With a 1% SeleniumSulfide/1% Salicylic Acid Shampoo Formulation for Seborrheic Dermatitis and Dandruff: A Multicenter Observational Study
- Macrophage Activation Syndrome/Secondary Hemophagocytic Lymphohistiocytosis in Adult‐Onset Still's Disease: An Uncommon Initial Presentation in a Young Nepalese Female: A Case Report
- Cepharanthine Suppresses Herpes Simplex Virus Type 1 Replication Through the Downregulation of the PI3K/Akt and p38 MAPK Signaling Pathways
- Short-Term Efficacy of Autologous Cellular Micrografts in Male and Female Androgenetic Alopecia: A Retrospective Cohort Study
- Milestones in Photocarcinogenesis
- RETRACTED: The investigation and comparison of the efficacy and safety of stromal vascular fraction (SVF), platelet rich plasma (PRP), and 1064‐nm Q‐switched Nd:YAG laser in reducing nanofat treated infraorbital dark circles and wrinkles: A controlled blinded randomized clinical trial
- Diagnostic delay, comorbid hidradenitis suppurativa and the prognostic value of bacterial culture in folliculitis decalvans: A cohort study
- Patient-Reported Flare Symptoms Following COVID-19 Vaccination in Systemic Lupus Erythematosus
- Comparative analysis of therapeutic outcomes in pediatric versus adult ophiasis-pattern alopecia areata: A review of treatment modalities and disease course
- The JAK/STAT signaling pathway: from bench to clinic
- The use of cyclosporine in dermatology: Part I
- Unraveling the ECM-Immune Cell Crosstalk in Skin Diseases
- Efficacy and safety of deuruxolitinib, an oral selective Janus kinase inhibitor, in adults with alopecia areata: Results from the Phase 3 randomized, controlled trial (THRIVE-AA1)
- Drug repurposing: A novel strategy to target cancer stem cells and therapeutic resistance
- Skin Structure, Physiology, and Pathology in Topical and Transdermal Drug Delivery
- Morphea: progress to date and the road ahead
- Deciphering the Complex Immunopathogenesis of Alopecia Areata
- New-onset Majocchi’s granuloma in two kidney transplant recipients under tacrolimus treatment
- Overview of Caffeine Effects on Human Health and Emerging Delivery Strategies
- Demodicosis in Different Age Groups and Alternative Treatment Options—A Review
- Cutaneous manifestations associated with immune checkpoint inhibitors
- Lenalidomide for refractory cutaneous manifestations of pediatric systemic lupus erythematosus
- Simvastatin/Ezetimibe Therapy for Recalcitrant Alopecia Areata: An Open Prospective Study of 14 Patients
- Non-motor Comorbidity of Myasthenia Gravis: Myasthenia Gravis as a Systemic Immunological Disorder Involving Non-motor Systems
- Biologics and Small Molecule Targeted Therapies for Pediatric Alopecia Areata, Psoriasis, Atopic Dermatitis, and Hidradenitis Suppurativa in the US: A Narrative Review
- Mesenchymal stem/stromal cell therapy in atopic dermatitis and chronic urticaria: immunological and clinical viewpoints